Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ir Catalyzed Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110407863A reveals a zirconium-catalyzed transfer borylation route. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN112979434A reveals a novel Suzuki coupling route for high-purity discotic liquid crystals, offering significant cost reduction in display material manufacturing.
Patent CN114516779A details site-selective bromination and borylation of DHR, enabling cost reduction in electronic chemical manufacturing and scalable OLED intermediate production.
Patent CN104725409A reveals novel iridium catalysis for high-purity aryl borate. Enables cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel synthesis method for L-6-hydroxytryptophan derivatives offers high yield and scalable production for pharmaceutical intermediates and polypeptide drug development.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.
Patent CN108299486A reveals iron catalysis for cyclopropyl boronic acid esters offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.